Metabolomics enables precision medicine: “A White Paper, Community Perspective”

[1]  Ronan M. T. Fleming,et al.  A systems approach reveals distinct metabolic strategies among the NCI-60 cancer cell lines , 2017, PLoS Comput. Biol..

[2]  Daniel M. Rotroff,et al.  A Genetic Response Score for Hydrochlorothiazide Use: Insights From Genomics and Metabolomics Integration. , 2016, Hypertension.

[3]  Noffisat O. Oki,et al.  Pharmacometabolomic Assessment of Metformin in Non-diabetic, African Americans , 2016, Front. Pharmacol..

[4]  A. Giordano,et al.  Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer , 2016, Oncotarget.

[5]  G. Mellgren,et al.  Lean-seafood intake decreases urinary markers of mitochondrial lipid and energy metabolism in healthy subjects: Metabolomics results from a randomized crossover intervention study. , 2016, Molecular nutrition & food research.

[6]  O. Fiehn.  Metabolomics by Gas Chromatography–Mass Spectrometry: Combined Targeted and Untargeted Profiling , 2016, Current protocols in molecular biology.

[7]  Krishna R. Kalari,et al.  TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics , 2016, Molecular Psychiatry.

[8]  K. Kim,et al.  Food metabolomics: from farm to human. , 2016, Current opinion in biotechnology.

[9]  Daniel M. Rotroff,et al.  Pharmacometabolomic Assessments of Atenolol and Hydrochlorothiazide Treatment Reveal Novel Drug Response Phenotypes , 2015, CPT: pharmacometrics & systems pharmacology.

[10]  P. MacDonald,et al.  Adenylosuccinate Is an Insulin Secretagogue Derived from Glucose-Induced Purine Metabolism. , 2015, Cell reports.

[11]  T. Hankemeier,et al.  Oxylipid Profile of Low‐Dose Aspirin Exposure: A Pharmacometabolomics Study , 2015, Journal of the American Heart Association.

[12]  S. Yusuf,et al.  The Relationship Between Trimethylamine-N-Oxide and Prevalent Cardiovascular Disease in a Multiethnic Population Living in Canada. , 2015, The Canadian journal of cardiology.

[13]  H. Yoon,et al.  Screening newborns for metabolic disorders based on targeted metabolomics using tandem mass spectrometry , 2015, Annals of pediatric endocrinology & metabolism.

[14]  Guangji Wang,et al.  A Pharmacometabonomic Approach To Predicting Metabolic Phenotypes and Pharmacokinetic Parameters of Atorvastatin in Healthy Volunteers. , 2015, Journal of proteome research.

[15]  H. Vernon.  Inborn Errors of Metabolism: Advances in Diagnosis and Therapy. , 2015, JAMA pediatrics.

[16]  C. Gieger,et al.  Genetics of human metabolism: an update , 2015, Human molecular genetics.

[17]  R. Weinshilboum,et al.  Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision Medicine , 2015, Clinical pharmacology and therapeutics.

[18]  H. C. Bertram,et al.  Metabolomics to Explore Impact of Dairy Intake , 2015, Nutrients.

[19]  M. Loda,et al.  Innovation in metabolomics to improve personalized healthcare , 2015, Annals of the New York Academy of Sciences.

[20]  Coral Barbas,et al.  Controlling the quality of metabolomics data: new strategies to get the best out of the QC sample , 2015, Metabolomics.

[21]  A. Saghatelian,et al.  Defining the metabolome: size, flux, and regulation. , 2015, Molecular cell.

[22]  S. Bhattacharyya,et al.  Translational biomarkers of acetaminophen-induced acute liver injury , 2015, Archives of Toxicology.

[23]  J. Everett.  Pharmacometabonomics in humans: a new tool for personalized medicine. , 2015, Pharmacogenomics.

[24]  J. Versalovic,et al.  164 Gut Microbiome Biomarkers Are Associated With Clinical Response to a Low FODMAP Diet in Children With Irritable Bowel Syndrome , 2015 .

[25]  Ines Thiele,et al.  Systematic prediction of health-relevant human-microbial co-metabolism through a computational framework , 2015, Gut microbes.

[26]  F. Collins,et al.  A new initiative on precision medicine. , 2015, The New England journal of medicine.

[27]  Aoife O'Gorman,et al.  Metabolomics as a tool in nutritional research , 2015, Current opinion in lipidology.

[28]  F. Corrales,et al.  Discovery of nutritional biomarkers: future directions based on omics technologies , 2015, International journal of food sciences and nutrition.

[29]  Eytan Ruppin,et al.  Phenotype-based cell-specific metabolic modeling reveals metabolic liabilities of cancer , 2014, eLife.

[30]  D. Schoeller,et al.  Energy balance measurement: when something is not better than nothing , 2014, International Journal of Obesity.

[31]  Chirag J. Patel,et al.  Development of Exposome Correlations Globes to Map Out Environment-Wide Associations , 2014, Pacific Symposium on Biocomputing.

[32]  Krista A. Zanetti,et al.  The use of metabolomics in population-based research. , 2014, Advances in nutrition.

[33]  Oliver Fiehn,et al.  Comprehensive analysis of lipids in biological systems by liquid chromatography-mass spectrometry. , 2014, Trends in analytical chemistry : TRAC.

[34]  Douglas B. Kell,et al.  Molecular phenotyping of a UK population: defining the human serum metabolome , 2014, Metabolomics.

[35]  A. Shuldiner,et al.  Pharmacometabolomics Reveals That Serotonin Is Implicated in Aspirin Response Variability , 2014, CPT: pharmacometrics & systems pharmacology.

[36]  John C Lindon,et al.  The emergent role of metabolic phenotyping in dynamic patient stratification , 2014, Expert opinion on drug metabolism & toxicology.

[37]  John P. Overington,et al.  An atlas of genetic influences on human blood metabolites , 2014, Nature Genetics.

[38]  W. R. Wikoff,et al.  Is a Diabetes Mellitus–Linked Amino Acid Signature Associated With &bgr;-Blocker–Induced Impaired Fasting Glucose? , 2014, Circulation. Cardiovascular genetics.

[39]  D. Dunger,et al.  The development and validation of a fast and robust dried blood spot based lipid profiling method to study infant metabolism , 2014, Metabolomics.

[40]  R. Weinshilboum,et al.  Pharmacometabolomics: Implications for Clinical Pharmacology and Systems Pharmacology , 2014, Clinical pharmacology and therapeutics.

[41]  R. Krauss,et al.  Pharmacometabolomics of Statin Response , 2013, Clinical pharmacology and therapeutics.

[42]  T. Hankemeier,et al.  Integration of Pharmacometabolomic and Pharmacogenomic Approaches Reveals Novel Insights Into Antiplatelet Therapy , 2013, Clinical pharmacology and therapeutics.

[43]  R. Loo,et al.  Pharmacometabonomics and personalized medicine , 2013, Annals of clinical biochemistry.

[44]  Michael A. Schmidt,et al.  Personalized medicine in human space flight: using Omics based analyses to develop individualized countermeasures that enhance astronaut safety and performance , 2013, Metabolomics.

[45]  O. Fiehn,et al.  Purine Pathway Implicated in Mechanism of Resistance to Aspirin Therapy: Pharmacometabolomics-Informed-Pharmacogenomics , 2013, Clinical pharmacology and therapeutics.

[46]  L. Mondello.  Foodomics – Advanced Mass Spectrometry in Modern Food Science and Nutrition Alejandro Cifuentes, Ed. John Wiley & Sons, Inc. 2013 ISBN 978‐1‐118‐16945‐2 Hardcover, 580 pages € 118.40 , 2013 .

[47]  R. Krauss,et al.  Correction: Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment , 2013, PLoS ONE.

[48]  G. Omenn,et al.  Evolution of Translational Omics: Lessons Learned and the Path Forward , 2013 .

[49]  Liang Zheng,et al.  Succinate is an inflammatory signal that induces IL-1β through HIF-1α , 2013, Nature.

[50]  W. R. Wikoff,et al.  Pharmacometabolomics Reveals Racial Differences in Response to Atenolol Treatment , 2013, PloS one.

[51]  C. Barbas,et al.  Metabolomics of Diet‐related Diseases , 2013 .

[52]  Ronan M. T. Fleming,et al.  A community-driven global reconstruction of human metabolism , 2013, Nature Biotechnology.

[53]  W. R. Wikoff,et al.  Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo , 2013, Translational Psychiatry.

[54]  D. Wishart,et al.  Translational biomarker discovery in clinical metabolomics: an introductory tutorial , 2012, Metabolomics.

[55]  David Broadhurst,et al.  The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans. , 2012, Bioanalysis.

[56]  Christian Gieger,et al.  Genetic variation in metabolic phenotypes: study designs and applications , 2012, Nature Reviews Genetics.

[57]  S. Moco,et al.  Metabolomics view on gut microbiome modulation by polyphenol-rich foods. , 2012, Journal of proteome research.

[58]  Peter D. Karp,et al.  Metabolomics Reveals Amino Acids Contribute to Variation in Response to Simvastatin Treatment , 2012, PloS one.

[59]  S. Fischer,et al.  Untargeted Plasma Metabolite Profiling Reveals the Broad Systemic Consequences of Xanthine Oxidoreductase Inactivation in Mice , 2012, PloS one.

[60]  Ralf J. M. Weber,et al.  Mass appeal: metabolite identification in mass spectrometry-focused untargeted metabolomics , 2012, Metabolomics.

[61]  L. Cardon,et al.  Use of genome-wide association studies for drug repositioning , 2012, Nature Biotechnology.

[62]  Yusuke Nakamura,et al.  Merging pharmacometabolomics with pharmacogenomics using ‘1000 Genomes’ single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics , 2012, Pharmacogenetics and genomics.

[63]  J. Nicholson,et al.  A metabolic phenotyping approach to understanding relationships between metabolic syndrome and breast tumour responses to chemotherapy. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[64]  G. Siuzdak,et al.  Innovation: Metabolomics: the apogee of the omics trilogy , 2012, Nature Reviews Molecular Cell Biology.

[65]  H. Moseley,et al.  Stable isotope-resolved metabolomics and applications for drug development. , 2012, Pharmacology & therapeutics.

[66]  J. Lindon,et al.  Longitudinal pharmacometabonomics for predicting patient responses to therapy: drug metabolism, toxicity and efficacy , 2012, Expert opinion on drug metabolism & toxicology.

[67]  Caroline H. Johnson,et al.  Xenobiotic metabolomics: major impact on the metabolome. , 2012, Annual review of pharmacology and toxicology.

[68]  C. Gieger,et al.  Human metabolic individuality in biomedical and pharmaceutical research , 2011, Nature.

[69]  R. Krishnan,et al.  Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept , 2011, Translational Psychiatry.

[70]  Christian Gieger,et al.  A genome-wide association study of metabolic traits in human urine , 2011, Nature Genetics.

[71]  S. Clarke,et al.  Pharmacometabonomic Profiling as a Predictor of Toxicity in Patients with Inoperable Colorectal Cancer Treated with Capecitabine , 2011, Clinical Cancer Research.

[72]  D. Schaid,et al.  Glycine and a Glycine Dehydrogenase (GLDC) SNP as Citalopram/Escitalopram Response Biomarkers in Depression: Pharmacometabolomics‐Informed Pharmacogenomics , 2011, Clinical pharmacology and therapeutics.

[73]  M. Frisch,et al.  Antibiotic use and inflammatory bowel diseases in childhood , 2010, Gut.

[74]  M. McCullough,et al.  Dietary lignans: physiology and potential for cardiovascular disease risk reduction. , 2010, Nutrition reviews.

[75]  Jeremiah Stamler,et al.  Opening up the "Black Box": metabolic phenotyping and metabolome-wide association studies in epidemiology. , 2010, Journal of clinical epidemiology.

[76]  F. Wright,et al.  Use of Pharmaco‐Metabonomics for Early Prediction of Acetaminophen‐Induced Hepatotoxicity in Humans , 2010, Clinical pharmacology and therapeutics.

[77]  R. Krauss,et al.  Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study , 2010, Metabolomics.

[78]  John C Lindon,et al.  Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism , 2009, Proceedings of the National Academy of Sciences.

[79]  Ian D Wilson,et al.  Drugs, bugs, and personalized medicine: Pharmacometabonomics enters the ring , 2009, Proceedings of the National Academy of Sciences.

[80]  J. Jansson,et al.  Metabolomics Reveals Metabolic Biomarkers of Crohn's Disease , 2009, PloS one.

[81]  Oliver Fiehn,et al.  Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research , 2009, Metabolomics.

[82]  Joerg Henseler,et al.  Determination of Morphine and 6-Acetylmorphine in Blood With Use of Dried Blood Spots , 2008, Therapeutic drug monitoring.

[83]  P. Turnbaugh,et al.  An Invitation to the Marriage of Metagenomics and Metabolomics , 2008, Cell.

[84]  Irena Spasic,et al.  A GC-TOF-MS study of the stability of serum and urine metabolomes during the UK Biobank sample collection and preparation protocols. , 2008, International journal of epidemiology.

[85]  P. Elliott,et al.  High-throughput 1H NMR-based metabolic analysis of human serum and urine for large-scale epidemiological studies: validation study. , 2008, International journal of epidemiology.

[86]  D. Genser.  Food and Drug Interaction: Consequences for the Nutrition/Health Status , 2008, Annals of Nutrition and Metabolism.

[87]  R. Weinshilboum,et al.  Metabolomics: a global biochemical approach to drug response and disease. , 2008, Annual review of pharmacology and toxicology.

[88]  K. Krishnan,et al.  Metabolomic mapping of atypical antipsychotic effects in schizophrenia , 2007, Molecular Psychiatry.

[89]  J. Lindon,et al.  Pharmaco-metabonomic phenotyping and personalized drug treatment , 2006, Nature.

[90]  I. Wilson,et al.  Gut microorganisms, mammalian metabolism and personalized health care , 2005, Nature Reviews Microbiology.

[91]  Elaine Holmes,et al.  The challenges of modeling mammalian biocomplexity , 2004, Nature Biotechnology.

[92]  Martin Lindner,et al.  Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. , 2003, Pediatrics.

[93]  M. Bennett,et al.  The changing face of newborn screening: diagnosis of inborn errors of metabolism by tandem mass spectrometry. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[94]  U. Klotz,et al.  Influence of Diet and Nutritional Status on Drug Metabolism , 1996, Clinical pharmacokinetics.

[95]  Ines Thiele,et al.  Computational Modeling of Human Metabolism and Its Application to Systems Biomedicine. , 2016, Methods in molecular biology.

[96]  Gabi Kastenmüller,et al.  Biochemical insights from population studies with genetics and metabolomics. , 2016, Archives of biochemistry and biophysics.

[97]  G. Xie,et al.  Metabonomics in Translational Research for Personalized Medicine and Nutrition , 2015 .

[98]  R. Ismagilov,et al.  Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis , 2015 .

[99]  Royston Goodacre,et al.  Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. , 2011, Chemical Society reviews.

[100]  R. Goodacre.  Metabolomics of a superorganism. , 2007, The Journal of nutrition.

[101]  C A Halterman,et al.  Controlling quality. , 1982, Quintessence of dental technology.

[102]  Genome-wide association study identifies novel genetic variants contributing to variation in blood metabolite levels , 2022 .